Wynn Resorts and its partners have earmarked land for a potential second integrated resort in Ras Al Khaimah, signaling long-term ambitions for expanding its gambling and hospitality footprint in the ...

You can use ChatGPT to write essays and for a myriad of other tasks, but did you know, you can create graphs, charts, and diagrams as well in ChatGPT? Yes, with the ...

The athleisure brand, which is part-owned by actor Kate Hudson, is understood to be planning its first store opening in the UK in 2026 and has said that more stores could follow, This is Money ...

Plans to remove age as a factor in deciding whether someone is capable of working are backed by Trump’s “Grim Reaper,” Russell Vought. Reporter The Trump administration is reportedly plotting a major ...

President Trump and GOP lawmakers are itching to make a potential government shutdown as painful as possible for Democrats as negotiations show few signs of progress with less than a week to go before ...

MANILA, Philippines — The Department of Agriculture (DA) is drawing up a new roadmap to ensure a steady supply of vegetables and high-value crops, a measure that is part of a long-term plan to shield ...

President Donald Trump plans to fire a top prosecutor after he refused to bring charges against one of Trump’s leading political enemies due to a lack of evidence in the case. The president’s federal ...

A historic city-owned cemetery in Arlington will soon allow the public to purchase available burial plots after declaring over 1,100 gravesites as ‘abandoned.’ The Arlington Cemetery on Mary Street ...

In a significant move to streamline construction approvals and reduce bureaucratic delays, the Karnataka Government on Tuesday issued a notification exempting small-scale residential buildings in ...

The Lahore Development Authority (LDA) has announced that it will hand over possession of 4,300 residential plots in six blocks of LDA City during the current month. The decision was made in a meeting ...

PMV Pharmaceuticals has reported a 43% response rate in a midphase ovarian cancer trial, putting the biotech on a track it believes will lead to a filing for FDA approval in the first quarter of 2027.